Financhill
Back

DiaMedica Therapeutics Stock Predictions

DiaMedica Therapeutics Stock Forecast

  • Is DiaMedica Therapeutics Stock Undervalued?
    The current DiaMedica Therapeutics [DMAC] share price is $3.63. The Score for DMAC is 27, which is 46% below its historic median score of 50, and infers higher risk than normal.
  • DMAC is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will DiaMedica Therapeutics Stock Go Up Next Year?

Data Unavailable

DiaMedica Therapeutics Stock Rating

Data Unavailable

DiaMedica Therapeutics Stock Price History

Is DMAC stock going to rise?

  • Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and DMAC is experiencing slight selling pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
diamedica.com

52-Week Data

52-Week High:
6.82
52-Week Low:
3.11

Prediction Charts

Market Cap:
155.7M
Price in USD:
3.63
Volume:
82.7K
Beta:
1.19

Technical Analysis

SMA50:
3.92
SMA100:
4.39
SMA200:
4.70
52-Wk Change:
13.44%

Stock Predictions

  • Is DiaMedica Therapeutics stock public?
    Yes, DiaMedica Therapeutics is a publicly traded company.
  • What is the DiaMedica Therapeutics stock quote today?
    The DiaMedica Therapeutics stock price is 3.63 USD today.
  • How to buy DiaMedica Therapeutics stock online?
    You can buy DiaMedica Therapeutics shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Jun-23 3.79 3.65 3.82 3.55
Jun-24 3.85 3.73 3.94 3.64
Jun-25 3.83 3.95 3.95 3.58
Jun-26 3.98 3.81 3.98 3.75
Jun-27 3.81 3.84 3.94 3.70
Jun-30 3.80 3.90 3.99 3.75
Jul-1 3.90 3.57 3.98 3.52
Jul-2 3.60 3.57 3.75 3.48
Jul-3 3.57 3.76 3.81 3.55
Jul-7 3.73 3.63 3.84 3.57
Jul-8 3.67 3.65 3.77 3.61
Jul-9 3.65 3.85 3.88 3.65
Jul-10 3.75 3.67 3.82 3.66
Jul-11 3.67 3.63 3.70 3.58

DiaMedica Therapeutics Earnings

Data Unavailable

DiaMedica Therapeutics Forecast Revenue Growth

Data Unavailable

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, an increase next quarter of $0.01 per share, a decrease this year of $0.18 per share, and a decrease next year of $0.02 per share.

* DiaMedica Therapeutics stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.